A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 3,090 shares of AXNX stock, worth $217,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,090
Previous 3,062 0.91%
Holding current value
$217,690
Previous $205,000 4.88%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$67.3 - $69.67 $1,884 - $1,950
28 Added 0.91%
3,090 $215,000
Q2 2024

Aug 12, 2024

BUY
$66.47 - $69.65 $9,438 - $9,890
142 Added 4.86%
3,062 $205,000
Q1 2024

May 09, 2024

BUY
$56.67 - $69.36 $165,476 - $202,531
2,920 New
2,920 $201,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.46B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.